Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Income from Continuing Operations (2016 - 2025)

Abeona Therapeutics has reported Income from Continuing Operations over the past 15 years, most recently at 20460000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 20460000.0 for Q4 2025, down 120.17% from a year ago — trailing twelve months through Dec 2025 was 77999000.0 (up 264.42% YoY), and the annual figure for FY2025 was 71183000.0, up 211.69%.
  • Income from Continuing Operations for Q4 2025 was 20460000.0 at Abeona Therapeutics, down from 5161000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for ABEO hit a ceiling of 124345000.0 in Q2 2025 and a floor of 46669000.0 in Q4 2021.
  • Median Income from Continuing Operations over the past 5 years was 13216000.0 (2022), compared with a mean of 8101750.0.
  • Biggest five-year swings in Income from Continuing Operations: plummeted 194.85% in 2021 and later soared 1578.98% in 2025.
  • Abeona Therapeutics' Income from Continuing Operations stood at 46669000.0 in 2021, then skyrocketed by 71.9% to 13114000.0 in 2022, then fell by 1.56% to 13318000.0 in 2023, then surged by 30.22% to 9293000.0 in 2024, then tumbled by 120.17% to 20460000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 20460000.0 (Q4 2025), 5161000.0 (Q3 2025), and 124345000.0 (Q2 2025) per Business Quant data.